SCHEMBL905405

SCHEMBL905405

CC(C)(C)[CH]O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1099338 0.74
SCHEMBL272050 0.74
SCHEMBL8991671 0.70
SCHEMBL3024112 0.70
SCHEMBL12646454 0.67
SCHEMBL322610 0.67
SCHEMBL5975691 0.67
SCHEMBL19510356 0.65
Tert-Butanol SCHEMBL1134092 0.60
Formic Acid SCHEMBL16589400 0.60 TDP1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 385 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210330678-A1 PAPD5 INHIBITORS AND METHODS OF USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-10-28 US claimed
EP-3846808-A2 PAPD5 INHIBITORS AND METHODS OF USE THEREOF CHILDREN'S MEDICAL CENTER CORPORATION (US) 2021-07-14 EP claimed
EP-2960233-B1 NEW THERAPEUTIC AGENTS CANCER RESEARCH TECH LTD (GB) 2019-10-30 EP claimed
US-20190048020-A1 DEUTERIUM-MODIFIED CFTR MODULATORS CONCERT PHARMACEUTICALS, INC. 2019-02-14 US claimed
CN-106700944-B A kind of synthetic alkali, A are to sapphire polishing liquid and preparation method thereof 北京国瑞升科技股份有限公司 2018-08-21 CN claimed
US-20180118684-A1 THERAPEUTIC AGENTS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2018-05-03 US claimed
CN-106700944-A Synthetic alkali, A-direction sapphire polishing solution and preparation method thereof 北京国瑞升科技股份有限公司 2017-05-24 CN claimed
US-9358222-B2 Therapeutic agents CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2016-06-07 US claimed
EP-2960233-A1 NEW THERAPEUTIC AGENTS Cancer Research Technology Limited (GB) 2015-12-30 EP claimed
US-8618158-B2 Therapeutic agents CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2013-12-31 US claimed
EP-1108000-A1 PROCESS FOR THE PREPARATION OF SUBSTITUTED AMIDO PHTHALOCYANINE DERIVATIVES AND SUBSTITUTED AMIDO PHTHALOCYANINE DERIVATIVES Ciba SC Holding AG (CH) 2001-06-20 EP claimed
EP-1108001-A1 PIGMENT COMPOSITIONS CONTAINING SUBSTITUTED AMIDO PHTHALOCYANINE DERIVATIVES Ciba SC Holding AG (CH) 2001-06-20 EP claimed
CN-1056140-C Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease SANKYO CO (JP) 2000-09-06 CN claimed
WO-2000012633-A1 PIGMENT COMPOSITIONS CONTAINING SUBSTITUTED AMIDO PHTHALOCYANINE DERIVATIVES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-03-09 WO claimed
WO-2000012632-A1 PROCESS FOR THE PREPARATION OF SUBSTITUTED AMIDO PHTHALOCYANINE DERIVATIVES AND SUBSTITUTED AMIDO PHTHALOCYANINE DERIVATIVES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-03-09 WO claimed
EP-0603001-B1 Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease SANKYO CO (JP) 1998-08-26 EP claimed
US-5459148-A Cardiovascular disorders SANKYO COMPANY, LIMITED (JP) 1995-10-17 US claimed
CN-1095374-A Biphenyl derivatives, their preparation and they are in the application for the treatment of hypertension and cardiac disease SANKYO CO (JP) 1994-11-23 CN claimed
EP-0603001-A1 Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease SANKYO COMPANY LIMITED (JP) 1994-06-22 EP claimed
EP-0042154-B1 NEW CEPHEM COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-04-15 EP claimed